Skip to main content
Premium Trial:

Request an Annual Quote

Nicoya Lifesciences OpenSPR-XT

Nicoya Lifesciences has launched OpenSPR-XT, a fully automated molecular analysis instrument based on the company's OpenSPR instrument. The OpenSPR-XT is a surface plasmon resonance instrument that uses proprietary nanotechnology-based sensors to provide high-quality molecular interaction data at a fraction of the cost of traditional SPR instruments. The product provides crucial data needed by life sciences researchers, such as binding kinetics, affinity, and specificity of proteins, antibodies, nucleic acids, small molecules, and more. Combining the technology with robust and user-friendly automation, the product saves time, reduces errors, and improves data quality and repeatability, according to the company.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.